Product Code: ETC6738047 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Bispecific Antibody Therapeutics Contract Manufacturing Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Bispecific Antibody Therapeutics Contract Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 China Bispecific Antibody Therapeutics Contract Manufacturing Market - Industry Life Cycle |
3.4 China Bispecific Antibody Therapeutics Contract Manufacturing Market - Porter's Five Forces |
3.5 China Bispecific Antibody Therapeutics Contract Manufacturing Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 China Bispecific Antibody Therapeutics Contract Manufacturing Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 China Bispecific Antibody Therapeutics Contract Manufacturing Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 China Bispecific Antibody Therapeutics Contract Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine |
4.2.2 Growing prevalence of chronic diseases in China |
4.2.3 Advancements in biotechnology and biopharmaceuticals research and development |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for biopharmaceutical manufacturing in China |
4.3.2 Lack of skilled workforce specialized in bispecific antibody therapeutics manufacturing |
4.3.3 Limited infrastructure and resources for contract manufacturing of bi-specific antibodies in China |
5 China Bispecific Antibody Therapeutics Contract Manufacturing Market Trends |
6 China Bispecific Antibody Therapeutics Contract Manufacturing Market, By Types |
6.1 China Bispecific Antibody Therapeutics Contract Manufacturing Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 China Bispecific Antibody Therapeutics Contract Manufacturing Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 China Bispecific Antibody Therapeutics Contract Manufacturing Market Revenues & Volume, By Cancer, 2021- 2031F |
6.1.4 China Bispecific Antibody Therapeutics Contract Manufacturing Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.1.5 China Bispecific Antibody Therapeutics Contract Manufacturing Market Revenues & Volume, By Autoinflammatory and autoimmune diseases, 2021- 2031F |
6.1.6 China Bispecific Antibody Therapeutics Contract Manufacturing Market Revenues & Volume, By CNS Conditions, 2021- 2031F |
6.1.7 China Bispecific Antibody Therapeutics Contract Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Bispecific Antibody Therapeutics Contract Manufacturing Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 China Bispecific Antibody Therapeutics Contract Manufacturing Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.3 China Bispecific Antibody Therapeutics Contract Manufacturing Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2.4 China Bispecific Antibody Therapeutics Contract Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Bispecific Antibody Therapeutics Contract Manufacturing Market, By End-use |
6.3.1 Overview and Analysis |
6.3.2 China Bispecific Antibody Therapeutics Contract Manufacturing Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.3.3 China Bispecific Antibody Therapeutics Contract Manufacturing Market Revenues & Volume, By Biopharmaceutical Companies, 2021- 2031F |
6.3.4 China Bispecific Antibody Therapeutics Contract Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
7 China Bispecific Antibody Therapeutics Contract Manufacturing Market Import-Export Trade Statistics |
7.1 China Bispecific Antibody Therapeutics Contract Manufacturing Market Export to Major Countries |
7.2 China Bispecific Antibody Therapeutics Contract Manufacturing Market Imports from Major Countries |
8 China Bispecific Antibody Therapeutics Contract Manufacturing Market Key Performance Indicators |
8.1 Percentage increase in research and development investment by biopharmaceutical companies in China |
8.2 Number of collaborations between biotech companies and contract manufacturing organizations in China |
8.3 Growth in the number of bi-specific antibody therapeutics in preclinical and clinical development in China |
9 China Bispecific Antibody Therapeutics Contract Manufacturing Market - Opportunity Assessment |
9.1 China Bispecific Antibody Therapeutics Contract Manufacturing Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 China Bispecific Antibody Therapeutics Contract Manufacturing Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 China Bispecific Antibody Therapeutics Contract Manufacturing Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 China Bispecific Antibody Therapeutics Contract Manufacturing Market - Competitive Landscape |
10.1 China Bispecific Antibody Therapeutics Contract Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 China Bispecific Antibody Therapeutics Contract Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |